Canton Strategic Holdings (CNTN) Equity Average (2021 - 2026)
Canton Strategic Holdings posted quarterly Equity Average of $433.9 million for Q1 2026, up 175919.52% year-on-year from N/an in Q1 2025, and up 114.74% on a QoQ basis from $202.0 million in Q4 2025.
Canton Strategic Holdings (CNTN) has 6 years of Equity Average data on file, last reported at $433.9 million in Q1 2026.
- For the quarter ending Q1 2026, Equity Average rose 175919.52% year-over-year to $433.9 million; the trailing twelve-month figure through Mar 2026 stood at $433.9 million (up 175919.52% YoY), and the FY2025 full-year result was $199.6 million, up 3724.45% from the prior year.
- Equity Average for Q1 2026 stood at $433.9 million, up from $202.0 million in the prior quarter.
- Across five years, Equity Average topped out at $433.9 million in Q1 2026 and bottomed at -$223656.0 in Q2 2025.
- The 5-year median for Equity Average is $4.9 million (2024), against an average of $41.4 million.
- The widest annual swing landed in 2025, when Equity Average sank 103.25%; it then jumped 175919.52% in 2026.
- A 5-year view of Equity Average shows it stood at $6.3 million in 2022, then declined by 13.99% to $5.4 million in 2023, then plunged by 60.28% to $2.2 million in 2024, then jumped by 9242.49% to $202.0 million in 2025, then soared by 114.74% to $433.9 million in 2026.
- The last three Equity Average figures came in at $433.9 million (Q1 2026), $202.0 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 3.76 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 21.35 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 19.01 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 31.34 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 932.28 Mn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | 433.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 433.86 Mn |
| Dec 31, 2025 | 202.04 Mn |
| Sep 30, 2025 | 3.26 Mn |
| Jun 30, 2025 | -223,656.00 |
| Mar 31, 2025 | 246,485.50 |
| Dec 31, 2024 | 2.16 Mn |
| Sep 30, 2024 | 4.86 Mn |
| Jun 30, 2024 | 6.87 Mn |
| Mar 31, 2024 | 8.09 Mn |
| Dec 31, 2023 | 5.44 Mn |
| Sep 30, 2023 | 2.41 Mn |
| Jun 30, 2023 | 3.13 Mn |
| Mar 31, 2023 | 4.37 Mn |
| Dec 31, 2022 | 6.33 Mn |
| Sep 30, 2022 | 8.08 Mn |
| Jun 30, 2022 | 9.69 Mn |
| Mar 31, 2022 | 2.83 Mn |
| Dec 31, 2021 | -5.91 Mn |
| Sep 30, 2021 | -6.72 Mn |
| Jun 30, 2021 | -5.79 Mn |
| Mar 31, 2021 | -4.51 Mn |